Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...

Lateone monsoon evening in Tiruppur, a textile buyer ran two fingers across a swatch he couldn’t quite place. It felt like ...

Discover Revvity, Inc.’s latest earnings, cloud growth, and $1B buyback. Click for my updated look at RVTY stock and why I ...

Love her or roll your eyes, Cathie Wood’s bets are virtually impossible for investors to miss. With clear theses and gutsy ...

Professor David Williams, a New Zealander working on gene therapy at UCLA, has warned that the Bill is “unfair to farmers” and based on false assumptions about precision and safety. He points to ...

Overview of Epigenetics MarketThe global Epigenetics Market is valued at USD 2.56 Billion in 2024 and is projected to reach a value of USD 9.11 Billion by 2035 at a CAGR (Compound Annual Growth Rate) ...

I’ve narrowed the spotlight to three tools that consistently beat GPTZero, Turnitin, and Copyleaks in independent ...

Ark Invest Block Inc shares purchase totals $30.9M across ARKK, ARKW, and ARKF, as Cathie Wood boosts exposure to crypto and ...

A lthough still in its early days, CRISPR has already been called the most powerful scientific tool of the century. Using ...

In a world first, a bespoke gene-editing therapy benefitted one child. Now reseachers plan to launch a clinical trial of the ...

Intellia Therapeutics said it is pausing two late-stage CRISPR gene-editing trials after a patient in one study was hospitalized with liver damage.